ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
연어 칼시토닌 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 16억 달러로 성장할 전망이며, CAGR은 5.7%로 성장이 예측됩니다. 예측 기간 동안 예상되는 성장은 헬스케어 지출 증가, 호르몬 관련 요법 사용 확대, 펩타이드 약물 전달, 바이오 의약품 연구 개발 강화, 유리한 규제 당국의 승인에 의해 이루어집니다. 이 기간의 주요 동향에는 선진적인 펩타이드 합성법, 나노입자 기반 약물 전달 시스템, 서방성 전달 기술, 재조합 DNA 기술, 3D 프린팅의 진보가 포함됩니다.
골다공증의 이환율 상승은 향후 연어 칼시토닌 시장의 성장을 이끌 것으로 예측됩니다. 골다공증은 골밀도 저하 및 골절 위험 상승을 특징으로 하는 병세이며, 주로 노인, 특히 폐경 후 여성이 이환합니다. 평균 수명의 장기화로 인해 골밀도 저하에 취약한 고령자가 증가하고 있습니다. 연어 칼시토닌은 골 흡수를 억제해 골량 감소를 늦추고 이 환자의 골밀도를 유지해 골다공증 관리를 돕습니다. 예를 들어 2023년 10월 캐나다에 본사를 둔 전문지인 Canadian Medical Association Journal이 발표한 보고서에 따르면 200만 명 이상의 캐나다인이 골다공증에 이환되고 있으며 매년 10만 명당 약 150명이 고관절 골절을 경험하고 있습니다. 따라서 골다공증의 유병률 증가가 연어 칼시토닌 시장의 확대에 박차를 가하고 있습니다.
연어 칼시토닌 시장의 주요 기업은 치료 효과 및 환자의 결과를 개선하기 위해 칼슘 조정제와 같은 혁신적인 솔루션의 개발에 주력하고 있습니다. 칼슘 조정제란 혈액과 뼈 속의 칼슘 농도를 관리하고 적절한 뼈의 형성과 유지, 대사 균형을 지원하는 물질과 메커니즘을 말합니다. 예를 들어 2025년 2월 독일에 본사를 둔 제약회사 프레제니우스 카비는 증후성 골 페젯병과 고칼슘혈증을 치료하기 위한 합성 연어 칼시토닌 주사제 USP를 발표했습니다. 본 합성제제는 증후성 골페젯병, 고칼슘혈증, 폐경 후 골다공증으로 다른 치료법이 적합하지 않은 경우에 적응합니다. 400i.U./2mL(200i.U./mL)의 멀티 용량 바이알로 제형화, 충전, 포장을 모두 미국에서 시행하고 있으며, 국내 의약품 제조와 공급망 강화에 대한 프레제니우스 곰팡이의 헌신적인 노력이 강조되고 있습니다. 이 주사제의 출시로 프레제니우스 곰팡이의 제네릭 주사제 포트폴리오는 확대되어 환자에게 저렴한 가격으로 신뢰성 높은 치료 선택지를 제공하는 것을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 연어 칼시토닌 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 연어 칼시토닌 시장 : 성장률 분석
세계의 연어 칼시토닌 시장 실적 : 규모 및 성장(2019-2024년)
세계의 연어 칼시토닌 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 연어 칼시토닌 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 연어 칼시토닌 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
스프레이
주사
세계의 연어 칼시토닌 시장 : 제형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정맥내
피하
코 스프레이
기타
세계의 연어 칼시토닌 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 연어 칼시토닌 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
골다공증
뼈 패젯병
고칼슘혈증
골수종
기타
세계의 연어 칼시토닌 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
약국
온라인 약국
기타
세계의 연어 칼시토닌 시장 : 스프레이별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
코 스프레이
경구 스프레이
세계의 연어 칼시토닌 시장 : 주사별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
피하 주사
근육내 주사
정맥 주사
제7장 지역별 및 국가별 분석
세계의 연어 칼시토닌 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 연어 칼시토닌 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
연어 칼시토닌 시장 : 경쟁 구도
연어 칼시토닌 시장 : 기업 프로파일
Other End Users
Sanofi SA
Boehringer Ingelheim International GmbH
Viatris Inc.
Fresenius Kabi AG
제31장 기타 주요 기업 및 혁신 기업
Sun Pharmaceutical Industries Limited
Dr. Reddy's Laboratories Limited
Cipla Limited
Hikma Pharmaceuticals plc
Endo International plc
Asahi Kasei Pharma Corporation
Anhui Anke BIoTechnology(Group) Co. Ltd.
Hybio Pharmaceutical Co. Ltd.
Tokyo Chemical Industry Co. Ltd.
Santa Cruz BIoTechnology Inc.
HRV Global Life Sciences Private Limited
AdvaCare Pharma USA LLC
BCN Peptides SL
Leucadia Pharmaceuticals Inc.
Polypeptide Group AB
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
연어 칼시토닌 시장(2029년) : 새로운 기회를 제공하는 국가
연어 칼시토닌 시장(2029년) : 새로운 기회를 제공하는 부문
연어 칼시토닌 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Calcitonin-salmon is a synthetic or recombinant version of the calcitonin hormone, originally sourced from salmon, used as a medication to regulate calcium levels and support bone health. It functions by inhibiting osteoclast activity-the cells that break down bone-thereby slowing bone loss and lowering calcium concentrations in the blood.
The primary forms of calcitonin-salmon include spray and injection. The spray refers to a nasal formulation used to deliver the hormone for treating conditions like osteoporosis. This medication is available in several dosage forms, such as intravenous, subcutaneous, and nasal spray, and is distributed through hospital pharmacies, retail pharmacies, and online platforms. Its applications include treating osteoporosis, Paget's disease of bone, hypercalcemia, myeloma, and other conditions, and it is used across various settings including clinics, pharmacies, and online channels.
The calcitonin salmon market research report is one of a series of new reports from The Business Research Company that provides calcitonin salmon market statistics, including calcitonin salmon industry global market size, regional shares, competitors with a calcitonin salmon market share, calcitonin salmon market segments, market trends and opportunities, and any further data you may need to thrive in the calcitonin salmon industry. This calcitonin salmon market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The calcitonin salmon market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The increase during the historical period is due to an aging worldwide population, greater awareness of bone health, a growing number of fractures, improvements in injectable drug formulations, and the expansion of research and development efforts.
The calcitonin salmon market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth expected in the forecast period is driven by increasing healthcare spending, expanded use of hormone-related therapies, peptide drug delivery, enhanced biopharmaceutical research and development, and favorable regulatory approvals. Key trends during this period involve advanced peptide synthesis methods, nanoparticle-based drug delivery systems, sustained-release delivery technologies, recombinant DNA technology, and 3D printing advancements.
The rising incidence of osteoporosis is anticipated to drive the growth of the calcitonin salmon market in the future. Osteoporosis is a medical condition marked by reduced bone density and a higher risk of fractures, mainly affecting older adults, particularly postmenopausal women. The condition is increasing due to longer life expectancy, resulting in a larger aging population vulnerable to bone density loss. Calcitonin salmon aids in managing osteoporosis by inhibiting bone resorption, slowing down bone loss, and helping to maintain bone density in affected individuals. For example, an October 2023 report from the Canadian Medical Association Journal, a peer-reviewed journal based in Canada, stated that over 2 million Canadians live with osteoporosis, and approximately 150 per 100,000 experience hip fractures annually, one of the disease's most severe outcomes. Hence, the growing prevalence of osteoporosis is fueling the expansion of the calcitonin salmon market.
Key companies in the calcitonin salmon market are concentrating on developing innovative solutions, such as calcium regulators, to improve treatment efficacy and patient outcomes. A calcium regulator is a substance or mechanism that helps manage calcium levels in the blood and bones, supporting proper bone formation, maintenance, and metabolic balance. For example, in February 2025, Fresenius Kabi, a pharmaceutical company based in Germany, introduced a synthetic calcitonin salmon injection, USP, to treat symptomatic Paget's disease of the bone and hypercalcemia. This synthetic product is indicated for symptomatic Paget's disease, hypercalcemia, and postmenopausal osteoporosis when other treatments are not suitable. It comes in 400 I.U./2 mL (200 I.U./mL) multi-dose vials and is fully formulated, filled, and packaged in the United States, highlighting Fresenius Kabi's dedication to strengthening domestic pharmaceutical manufacturing and supply chains. The launch of this injection expands the company's generic injectable portfolio, aiming to offer affordable and dependable treatment options for patients.
In April 2022, Hikma Pharmaceuticals plc., a pharmaceutical company based in the UK, acquired Custopharm Inc. for an undisclosed sum. Through this acquisition, Hikma intends to bolster its U.S. injectables business by broadening its product range, improving its research and development capabilities, and speeding up growth in the generic sterile injectable market. Custopharm Inc. is a U.S.-based supplier of complex sterile generic injectable products that include calcitonin salmon.
Major players in the calcitonin salmon market are Sanofi S.A, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Anhui Anke Biotechnology (Group) Co. Ltd., Hybio Pharmaceutical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Santa Cruz Biotechnology Inc., HRV Global Life Sciences Private Limited, AdvaCare Pharma USA LLC, BCN Peptides S.L., Leucadia Pharmaceuticals Inc., Polypeptide Group AB, LKT Laboratories Inc.
North America was the largest region in the calcitonin salmon market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in calcitonin salmon report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the calcitonin salmon market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The calcitonin salmon market consists of sales of nasal spray, auto-injectors, lyophilized powder, nasal gel, and oral spray or tablet. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Calcitonin Salmon Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on calcitonin salmon market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for calcitonin salmon ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The calcitonin salmon market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Spray; Injection
2) By Dosage Form: Intravenous; Subcutaneous; Nasal Spray; Other Dosage Forms
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By Application: Osteoporosis; Paget's Disease Of Bone; Hypercalcemia; Myeloma; Other Applications
5) By End User: Hospitals; Clinics; Pharmacies; Online Pharmacies; Other End Users
Subsegments:
1) By Spray: Nasal Spray; Oral Spray
2) By Injection: Subcutaneous Injection; Intramuscular Injection; Intravenous Injection
Companies Mentioned: Sanofi S.A; Boehringer Ingelheim International GmbH; Viatris Inc.; Fresenius Kabi AG; Sun Pharmaceutical Industries Limited
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Calcitonin Salmon Market Characteristics
3. Calcitonin Salmon Market Trends And Strategies
4. Calcitonin Salmon Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Calcitonin Salmon Growth Analysis And Strategic Analysis Framework
5.1. Global Calcitonin Salmon PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Calcitonin Salmon Market Growth Rate Analysis
5.4. Global Calcitonin Salmon Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Calcitonin Salmon Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Calcitonin Salmon Total Addressable Market (TAM)
6. Calcitonin Salmon Market Segmentation
6.1. Global Calcitonin Salmon Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spray
Injection
6.2. Global Calcitonin Salmon Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
Nasal Spray
Other Dosage Forms
6.3. Global Calcitonin Salmon Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Calcitonin Salmon Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Osteoporosis
Paget's Disease Of Bone
Hypercalcemia
Myeloma
Other Applications
6.5. Global Calcitonin Salmon Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Pharmacies
Online Pharmacies
Other End Users
6.6. Global Calcitonin Salmon Market, Sub-Segmentation Of Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nasal Spray
Oral Spray
6.7. Global Calcitonin Salmon Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous Injection
Intramuscular Injection
Intravenous Injection
7. Calcitonin Salmon Market Regional And Country Analysis
7.1. Global Calcitonin Salmon Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Calcitonin Salmon Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
